首页> 外文期刊>The Laryngoscope: A Medical Journal for Clinical and Research Contributions in Otolaryngology, Head and Neck Medicine and Surgery, Facial Plastic and Reconstructive Surgery .. >Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.
【24h】

Validity of the Western blot immunoassay for heat shock protein-70 in associated and isolated immunorelated inner ear disease.

机译:Western blot免疫测定在相关和分离的免疫相关内耳疾病中对热休克蛋白70的有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess the validity of the Western blot immunoassay for heat shock protein-70 (hsp-70) for diagnosis of autoimmune inner ear disease. STUDY DESIGN: Retrospective study of 53 patients affected by sudden deafness (n = 19), idiopathic progressive sensorineural hearing loss (n = 24), and Meniere's disease (n = 10) who were treated from 1995 to 1999. The clinical course and response to corticosteroid were evaluated. METHODS: A purified hsp-70 antigen from bovine kidney cell line was used for the Western blot immunoassay. RESULTS: Only five patients (9.4%) showed anti--hsp-70 antibodies: Two presented a sudden sensorineural hearing loss (sudden deafness group), two showed an idiopathic progressive sensorineural hearing loss (idiopathic progressive sensorineural hearing loss group), and one was affected by fluctuating hearing loss (Meniere's disease group). A systemic autoimmune condition was observed in 29.1% of patients with idiopathic progressive sensorineural hearing loss. CONCLUSIONS: The low sensitivity of Western blot immunoassay for patients affected by idiopathic progressive sensorineural hearing loss and Meniere's disease may result from either the long time elapsed from the hearing loss and vertigo to the initial examination or from the increased percentage of cases of systemic autoimmune disease present in patients with idiopathic progressive sensorineural hearing loss. More studies to detect the immune-mediated inner ear disease in Western blot immunoassay-negative patients are required.
机译:目的:评估热休克蛋白70(hsp-70)的蛋白质印迹免疫分析在诊断自身免疫性内耳疾病中的有效性。研究设计:回顾性研究从1995年至1999年接受治疗的53例突发性耳聋(n = 19),特发性进行性感觉神经性听力丧失(n = 24)和美尼尔氏病(n = 10)的患者。临床过程和反应对皮质类固醇激素进行了评估。方法:采用牛肾细胞株纯化的hsp-70抗原进行Western blot免疫分析。结果:只有5例患者(9.4%)显示抗hsp-70抗体:2例出现突然的感音神经性听力丧失(突发性耳聋组),2例表现出特发性进行性感觉神经性听力丧失(特发性进行性感觉神经性听力丧失组),1例受波动性听力损失的影响(Meniere病组)。在特发性进行性感觉神经性听力损失的患者中,有29.1%的患者观察到全身性自身免疫疾病。结论:对于特发性进行性感觉神经性听力损失和梅尼埃病患者而言,Western blot免疫测定的敏感性较低,可能是由于听力损失和眩晕到开始初诊的时间过长或全身性自身免疫疾病病例增加所致目前患有特发性进行性感觉神经性听力损失的患者。需要更多的研究来检测免疫印迹阴性患者的免疫介导的内耳疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号